Total Payments
$400,076
2024 Payments
$134,179
Companies
49
Transactions
903
Medicare Patients
453
Medicare Billing
$65,873
Payment Breakdown by Category
Other$302,787 (75.7%)
Travel$37,964 (9.5%)
Consulting$36,576 (9.1%)
Food & Beverage$20,278 (5.1%)
Research$2,029 (0.5%)
Education$443.39 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $235,925 | 86 | 59.0% |
| Honoraria | $66,862 | 27 | 16.7% |
| Travel and Lodging | $37,964 | 91 | 9.5% |
| Consulting Fee | $36,576 | 19 | 9.1% |
| Food and Beverage | $20,278 | 672 | 5.1% |
| Unspecified | $2,029 | 1 | 0.5% |
| Education | $443.39 | 7 | 0.1% |
Payments by Type
General
$398,047
902 transactions
Research
$2,029
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $112,748 | 133 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $101,064 | 92 | $0 (2024) |
| EMD Serono, Inc. | $48,974 | 77 | $0 (2024) |
| Amgen Inc. | $38,092 | 68 | $0 (2024) |
| Biogen, Inc. | $28,361 | 88 | $0 (2024) |
| GENZYME CORPORATION | $22,900 | 41 | $0 (2024) |
| TG Therapeutics, Inc. | $20,268 | 26 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $9,412 | 12 | $0 (2023) |
| Genentech USA, Inc. | $8,261 | 36 | $0 (2024) |
| Celgene Corporation | $2,599 | 49 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134,179 | 174 | Alexion Pharmaceuticals, Inc. ($39,776) |
| 2023 | $178,636 | 303 | Alexion Pharmaceuticals, Inc. ($58,847) |
| 2022 | $75,045 | 315 | Horizon Therapeutics plc ($59,960) |
| 2021 | $10,058 | 78 | Genentech USA, Inc. ($4,000) |
| 2020 | $390.11 | 7 | Alexion Pharmaceuticals, Inc. ($124.78) |
| 2019 | $700.73 | 11 | UCB, Inc. ($249.98) |
| 2018 | $969.86 | 14 | Genentech USA, Inc. ($274.68) |
| 2017 | $96.37 | 1 | Acorda Therapeutics, Inc ($96.37) |
All Payment Transactions
903 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.02 | General |
| 12/17/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $1.09 | General |
| 12/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,614.00 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/08/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.24 | General |
| 12/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $1.27 | General |
| 11/26/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $698.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,770.00 | General |
| 11/21/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Amgen Inc. | UPLIZNA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Neurology | ||||||
| 11/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.11 | General |
| 11/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $1.10 | General |
| 11/12/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,228.00 | General |
| Category: Neurology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.15 | General |
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $796.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/02/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Inflammation/Rare Disease | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Satralizumab Treatment in Adults With AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorder: A Retrospective Case Series | F. Hoffmann-La Roche AG | $2,029 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 103 | 141 | $26,883 | $12,532 |
| 2022 | 6 | 239 | 315 | $89,527 | $37,464 |
| 2021 | 4 | 111 | 115 | $32,225 | $15,876 |
Total Patients
453
Total Services
571
Medicare Billing
$65,873
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 34 | 58 | $8,624 | $4,193 | 48.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 29 | 43 | $8,379 | $4,063 | 48.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 24 | 24 | $6,456 | $2,768 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $3,424 | $1,508 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 166 | $37,350 | $15,200 | 40.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 20 | 20 | $16,000 | $6,834 | 42.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 48 | $12,000 | $6,378 | 53.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $15,000 | $5,448 | 36.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $5,250 | $1,852 | 35.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $3,927 | $1,752 | 44.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $12,000 | $5,536 | 46.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $7,700 | $3,900 | 50.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 24 | $6,000 | $3,330 | 55.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 29 | $6,525 | $3,110 | 47.7% |
About Dr. Rosemarie Walch, DO
Dr. Rosemarie Walch, DO is a Neurology healthcare provider based in Owosso, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2016. The National Provider Identifier (NPI) number assigned to this provider is 1366803454.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rosemarie Walch, DO has received a total of $400,076 in payments from pharmaceutical and medical device companies, with $134,179 received in 2024. These payments were reported across 903 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($235,925).
As a Medicare-enrolled provider, Walch has provided services to 453 Medicare beneficiaries, totaling 571 services with total Medicare billing of $65,873. Data is available for 3 years (2021–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Owosso, MI
- Active Since 03/16/2016
- Last Updated 01/26/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1366803454
Products in Payments
- UPLIZNA (Drug) $112,748
- SOLIRIS (Biological) $48,825
- UPLIZNA (Biological) $31,099
- ULTOMIRIS (Biological) $27,281
- MAVENCLAD (Drug) $23,780
- Mavenclad (Drug) $23,464
- BRIUMVI (Drug) $20,268
- VUMERITY (Drug) $20,122
- ZEPOSIA (Drug) $8,482
- Tysabri (Biological) $6,359
- Enspryng (Biological) $3,787
- Ocrevus (Biological) $3,683
- OCREVUS (Biological) $2,392
- TYSABRI (Biological) $950.18
- KESIMPTA (Drug) $877.92
- Briviact (Drug) $642.45
- AUBAGIO (Drug) $598.60
- BOTOX (Biological) $488.63
- UBRELVY (Drug) $265.55
- Fycompa (Drug) $257.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Owosso
Dr. Rany Aburashed, D.o, D.O
Neurology — Payments: $1.2M
Neurology $1.2M
Robert Pace, Md, MD
Neurology — Payments: $901,128
Neurology $901,128
Margaret Frey, Do, DO
Neurology — Payments: $409,351
Neurology $409,351
Cara Leahy, Do, DO
Neurology — Payments: $115,077
Neurology $115,077
Anthony Brune, Do, DO
Neurology — Payments: $18,437
Neurology $18,437
Dustin Nowacek, Md, MD
Neurology — Payments: $8,682
Neurology $8,682